Another study employing the same technology facilitated the co‐delivery of DOX and a FOXM1 aptamer to lung tumour cells, leading to a pronounced increase in anti‐tumour effects, reduced metastasis and decreased cell proliferation, likely due to the role of FOXM1 in mitigating chemotherapy resistance.89 Here, FOXM1 is linked to neoplasm.